SCHEMBL18875142

SCHEMBL18875142

c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3cnccc3s2)ccc1-c1ccc(-c2nc3cnccc3s2)cc1N1c2ccccc2Oc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.41
NPC1 O15118 7/20 0.41
KDM4E B2RXH2 5/20 0.41
NFKB1 P19838 3/20 0.41
NFKB2 Q00653 3/20 0.41
RELA Q04206 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
PKM P14618 2/20 0.41
HPGD P15428 1/20 0.41
TDP2 O95551 1/20 0.36
APP P05067 4/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
POLB P06746 2/20 0.34
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18875167 0.91 RAB9A (0.41) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL18875138 0.87 RAB9A (0.54) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL23172351 0.85 RAB9A (0.45) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL18875123 0.84 RAB9A (0.41) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL18875153 0.83 RAB9A (0.40) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL18875172 0.82 RAB9A (0.40) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL18875147 0.82 NPC1 (0.34) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL18875201 0.81 RAB9A (0.48) RAB9ANPC1KDM4ENFKB1NFKB2
SCHEMBL18875131 0.79 TSHR (0.41) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL18875133 0.79 ALDH1A1 (0.48) RAB9ANPC1KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME WUHAN TIANMA MICROELECTRONICS CO., LTD.SHANGHAI BRANCH (CN) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170148996-A1 ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC OPTOELECTRONIC DEVICES COMPRISING THE SAME OR10J3, PPOX, OR51E2 RAB9A 2603/4885NPC1 3621/4885KDM4E 2416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.